A subset of pd-1-expressing cd56bright nk cells identifies patients with good response to immune checkpoint inhibitors in lung cancer

HIGHLIGHTS

• who: Marta Gascu00f3n-Ruiz and colleagues from the Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain have published the paper: A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer, in the Journal: (JOURNAL)
• what: The aim of the study is to analyze different subsets of T-lymphocytes and natural killer (NK) cells as predictive biomarkers in a cohort of patients with nonsmall cell lung cancer (NSCLC) treated with ICI. Pending on validation with a larger sample here the authors provide an analysis . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.